Skip to main content
SpringerLink
Log in

Effect of cyclophosphamide pretreatment on the short-term disposition and biliary excretion of adriamycin metabolites in rat

  • Original Articles
  • Cyclophosphamide and Adriamycin Disposition
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Summary

The effect of pretreatment with cyclophosphamide 180 mg/kg upon the short-term disposition of adriamycin in anesthetized rat 4 days later was studied. There was a significant decrease in plasma adriamycin clearance, from 125 to 48 ml/min/kg, and a significant decrease in the apparent volume of the peripheral compartment of adriamycin distribution, from 51.7 to 25.6 l/kg, in cyclophosphamide-pretreated as against control rats. Biliary excretion of adriamycin over 2.5 h was increased significantly by 114% in cyclophosphamide-pretreated rats and there was a small but nonsignificant increase in biliary adriamycinol excretion and a decrease in excretion of adriamycin aglycones. Cyclophosphamide pretreatment was associated with an 83% increase in bile flow. Cyclophosphamide pretreatment had no significant effect upon the utilization of adriamycin or upon the formation of adriamycin metabolites by rat isolated hepatocytes. The results suggest that NADPH-cytochrome P-450 reductase, which is decreased 40% by cyclophosphamide pretreatment, is not rate-limiting in elimination of adriamycin. Biliary excretion of adriamycin is increased when plasma adriamycin clearance is decreased, suggesting that cyclophosphamide pretreatment affects a pathway besides biliary excretion that is responsible for the short-term removal of adriamycin from plasma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Andrews PA, Brenner DE, Chan FTE, Kubo Hk, Bachur NR (1980) Facile and definitive determination of human adriamycin and daunorubicin metabolites by high-pressure liquid chromatography. Drug Metab Dispos 8: 152

    Google Scholar 

  2. Bachur NR (1979) Anthracycline antibiotic pharmacology and metabolism. Cancer Treat Rep 63: 817

    Google Scholar 

  3. Bachur NR, Gordon SL, Gee MV, Kon H (1979) NADPH-cytochrome P-450 reductase activation of quinone anticancer agents to free radicals. Proc Natl Acad Sci USA 76: 954

    Google Scholar 

  4. Baurain R, Deprez-DeCampaneere D, Trouet A (1979) Rapid determination of doxorubicin and its fluorescent metabolites by high-pressure liquid chromatography. Anal Biochem 94: 112

    Google Scholar 

  5. Broggini M, Colombo T, Martini A, Danelli MG (1980) Studies on the comparative distributions and biliary excretion of doxorubicin and 4′-epi-doxorubicin in mice and rats. Cancer Treat Rep 64: 897

    Google Scholar 

  6. Corbett TH, Griswold DP, Mayo JG, Laster WR, Schabel FM (1975) Cyclophosphamide-adriamycin combination chemotherapy of transplantable murine tumors. Cancer Res 35: 1568

    Google Scholar 

  7. Davis HL, Davis TL (1979) Daunorubicin and adriamycin in cancer treatment: An analysis of their roles and limitations. Cancer Treat Rep 63: 809

    Google Scholar 

  8. Driscoll JS, Hazard GF, Wood HB, Goldin A (1974) Structure-antitumor activity relationships among quinone derivatives. Cancer Chemother Rep [2] 4: 1

    Google Scholar 

  9. Eksborg S, Ehrsson H, Andersson I (1979) Reversed-phase liquid chromatographic determination of plasma levels of adriamycin and adriamycinol. J Chromatogr 164: 479

    Google Scholar 

  10. Evans WE, Crom WR, Yee GC, Green AA, Hayes A, Partt CB, Avery TL (1980) Adriamycin pharmacokinetics in children. Proc Am Assoc Cancer Res 21: 176

    Google Scholar 

  11. Gibaldi M, Perrier D (1975) In: Pharmacokinetics. Marcel Dekker, New York, pp 45–128 and pp 293–300

    Google Scholar 

  12. Gurtoo HL, Gessner T, Culliton P (1976) Studies of the effects of cyclophosphamide, vincristine, and prednisone on some hepatic oxidations and conjugations. Cancer Treat Rep 60: 1285

    Google Scholar 

  13. Israel M, Wilkinson PM, Pegg WJ, Frei E (1978) Hepatobiliary metabolism and excretion of adriamycin and N-trifluoroacetyl adriamycin-14-valerate in the rat. Cancer Res 38: 365

    Google Scholar 

  14. Klassen CD (1971) Studies on the increased biliary flow produced by phenobarbital in rats. J Pharmacol Exp Ther 176: 743–751

    Google Scholar 

  15. Marinello AJ, Berrigan MJ, Struck RF, Guengerich FP, Gurtoo HL (1981) Inhibition of NADPH-cytochrome P-450 reductase by cyclophosphamide and its metabolites. Biochem Biophys Res Commun 99: 399

    Google Scholar 

  16. Metzler CM, Elfring GL, McEwen AJ (1974) A package of computer programs for pharmacokinetic modeling. Biometrics 30: 562

    Google Scholar 

  17. Morgan LR, Hagardorn AN, Maddux B, Sutherland C, Carter RB, Krementz ET (1976) Pharmacology of weekly low-dose adriamycin in human breast cancer. Pharmacologist 18: 126

    Google Scholar 

  18. Muggia FM, Perloff M, Chia GA, Reed LJ, Escher GC (1974) Adriamycin (NSC-123127) in combination with cyclophosphamide (NSC-26271): A phase I and II evaluation. Cancer Chemother Rep 58: 919

    Google Scholar 

  19. Powis G, Svingen BA, Degraw C (1982) Iron-EDTA stimulated reduction of indicine N-oxide by the hepatic microsomal fraction, isolated hepatocytes, and the intact rat. Biochem Pharmacol 31: 293

    Google Scholar 

  20. Reich SD (1978) Clinical correlations of adriamycin pharmacology. Pharmacol Ther [C] 2: 239

    Google Scholar 

  21. Riggs CE, Benjamin RS, Serpick AA, Bachur NR (1977) Biliary disposition of adriamycin. Clin Pharmacol Ther 22: 234

    Google Scholar 

  22. Shinozawa S, Oda T (1981) Determination of adriamycin (doxorubicin) and related fluorescent compounds in rat lymph and gall by high-performance liquid chromatography. J Chromatogr 212: 323

    Google Scholar 

  23. Snedecor GW, Cochran WG (1976) Statistical methods, 6th edn. Iowa State University Press, Ames, p 59

    Google Scholar 

  24. Stewart AJ, Inaba T (1979) N-Demethylation of aminopyrine in vivo and in the isolated hepatocyte of the rat. Biochem Pharmacol 28: 461

    Google Scholar 

  25. Takanashi S, Bachur NR (1976) Adriamycin metabolism in man. Evidence from urinary metabolites. Drug Metab Dispos 4: 79

    CAS  PubMed  Google Scholar 

  26. Tavoloni N, Guarino AM (1980a) Bile secretory function: A determinant of adriamycin disposition. Arch Int Pharmacodyn 245: 180

    Google Scholar 

  27. Tavoloni N, Guarino AM (1980b) Biliary and urinary excretion of adriamycin in anesthetized rats. Pharmacology 20: 256

    Google Scholar 

  28. Wilkinson PM, Mawer GE (1974) The persistence of adriamycin in man and rat. Br J Clin Pharmacol 1: 241

    Google Scholar 

  29. Wilkinson PM, Israel M, Pegg WJ, Frei E (1979) Comparative metabolism and excretion of adriamycin in man, monkey, and rat. Cancer Chemother Pharmacol 2: 241

    Google Scholar 

  30. Williams BA, Tritton TR (1981) Photoinactivation of anthracyclines. Photochem Photobiol 34: 131

    Google Scholar 

  31. Yasukochi Y, Masters BSS (1976) Some properties of a detergent-solubilized NADPH-cytochrome c (cytochrome P-450) reductase purified by biospecific affinity chromatography. J Biol Chem 251: 5337

    Google Scholar 

  32. Yesair DW, Schwarztbach E, Schuck D, Denine EP, Asbell MA (1972) Comparative pharmacokinetics of daunomycin and adriamycin in several animal species. Cancer Res 32: 1177

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Developmental Oncology Research, Department of Oncology, Mayo Clinic, 55905, Rochester, MN, USA

    Neil Hartman, Peter J. Basseches & Garth Powis

Authors
  1. Neil Hartman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peter J. Basseches
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Garth Powis
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hartman, N., Basseches, P.J. & Powis, G. Effect of cyclophosphamide pretreatment on the short-term disposition and biliary excretion of adriamycin metabolites in rat. Cancer Chemother. Pharmacol. 10, 11–15 (1982). https://doi.org/10.1007/BF00257229

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00257229

Keywords

Search

Navigation